Lv1
60 积分 2023-06-30 加入
Tissue-specific mRNA delivery and prime editing with peptide–ionizable lipid nanoparticles
1天前
已完结
Watershed year of cell and gene therapy (CGT): A review of 2024 CGT approvals
2个月前
已完结
Amylin: emergent therapeutic opportunities in overweight, obesity and diabetes mellitus
4个月前
已完结
Selective amylin receptor agonism: promise beyond incretins
4个月前
已完结
Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial
4个月前
已完结
Eloralintide (LY3841136), a novel amylin receptor agonist for the treatment of obesity: From discovery to clinical proof of concept
4个月前
已完结
Amylin takes another shot at the obesity prize
4个月前
已完结
Binding sites and design strategies for small molecule GLP-1R Agonists
4个月前
已完结
Transferrin receptor–targeted anti-amyloid antibody enhances brain delivery and mitigates ARIA
5个月前
已完结
皖公网安备34019202002308
